Literature DB >> 32398201

Prevalence and risk factors of airflow obstruction in a Caribbean population.

L Conyette1, F Lutchmansingh2, S Sakhamuri2, D Simeon2, M A Ivey2, P Burney3, T Seemungal2.   

Abstract

SETTING: The prevalence of airflow obstruction (AO) in the Caribbean population is unknown.
OBJECTIVE: To measure the prevalence of and risk factors for AO (post-bronchodilator ratio of forced expiratory volume in 1 sec to forced vital capacity of <0.7) in the Trinidad and Tobago general population using the Burden of Obstructive Lung Disease methodology.
DESIGN: National cross-sectional, stratified, cluster sampling of adults aged ≥40 years.
RESULTS: AO prevalence was 9.5% among 1104 participants, most of whom were unaware of this. Compared to those aged 40-49 years, the adjusted odds ratio of AO by age group was 2.73 (60-69 years) and 3.30 (≥70 years). Risk factors for AO were unemployment (OR 4.31), being retired (OR 2.17), smoking ≥20 pack-years (OR 1.88) and exposure to dusty jobs for more than 1 year (OR 2.06). Related symptoms were history of wheezing, unscheduled visits to the doctor or admission to hospital for breathing problems and in subjects with at least one respiratory symptom (OR 1.90), at least one risk factor (OR 2.81), either symptoms or risk factors (OR 3.71) and both symptoms and risk factors (OR 5.78) (P < 0.05 in all cases).
CONCLUSION: AO prevalence in the general population of Trinidad and Tobago aged ≥40 years was 9.5%, almost all of which was undiagnosed. AO was associated with smoking, age >59 years, lack of employment and working in a dusty job.

Entities:  

Mesh:

Year:  2020        PMID: 32398201     DOI: 10.5588/ijtld.19.0578

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  1 in total

1.  Prevalence and incidence of chronic obstructive pulmonary disease in Latin America and the Caribbean: a systematic review and meta-analysis.

Authors:  Juan J Olortegui-Rodriguez; David R Soriano-Moreno; Alejandro Benites-Bullón; Pilar P Pelayo-Luis; Jorge Huaringa-Marcelo
Journal:  BMC Pulm Med       Date:  2022-07-16       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.